In the wiki it says: "Identify high risk patients defined by disease progression (or death) within 18 months from time of diagnosis using gene expression (RNA-seq or microarray based) variables with the option to include ISS and age (two known strong prognostic factors) and available cytogenetics" It does not say whether we can use gender. Can we use it?